Protein Sequencing Market Size

Market Size Snapshot

Note – Market size depicts the revenue generated over the financial year

The global market for protein characterization is expected to grow at a fast pace, with a market size of $1.4 billion in 2024, growing to $6.5 billion by 2035. It is expected to grow at a CAGR of 14.46% from 2025 to 2035. The increasing demand for individualized medicine, the rapid development of proteomics, and the rising prevalence of chronic diseases are the main driving forces for the expansion of the market. Next-generation sequencing and mass spectrometry have improved the accuracy and efficiency of protein characterization, which has attracted the attention of investors and has led to the establishment of a large number of alliances between industry players. Thermo Fisher, Agilent, and Illumina are the three major players in the market. For example, more and more companies are establishing alliances to develop new sequencing technology, and launching products with improved sequence capabilities. These efforts will not only enhance the competitiveness of these companies, but also further promote the development of the protein characterization industry, which will continue to grow steadily and meet the needs of the development of the biomedical and biotechnological industries.

Regional Market Size

Regional Deep Dive

The market for the sequencer of the proteins is growing rapidly in all the world regions, driven by the development of biotechnology, the rising demand for personal medicine and the growing prevalence of chronic diseases. Each region has its own characteristics that affect the dynamics of the market, such as the level of technological development, regulatory frameworks and research and development investment. North America is characterized by a strong presence of major players and high investment in innovation, while Europe is characterized by the regulatory framework and the development of cooperative research. The rapid industrialization and the development of the health care system in Asia-Pacific is driving the expansion of the market. In the Middle East and Africa, the lack of infrastructure is a major challenge, but the research centers are emerging. Latin America gradually increases its investment in biotechnology, which will lead to the development of the market in the coming years.

Europe

• The European Union's Horizon 2020 program is funding numerous projects focused on protein sequencing, promoting collaboration between academic institutions and industry players to drive technological advancements.
• Regulatory changes in the EU, particularly regarding data privacy and genetic information, are shaping the development and application of protein sequencing technologies, necessitating compliance from companies operating in the region.

Asia Pacific

• China's investment in biotechnology has surged, with government initiatives supporting the development of protein sequencing technologies, positioning the country as a key player in the global market.
• India is witnessing a rise in startups focused on bioinformatics and protein sequencing, driven by a growing emphasis on personalized medicine and healthcare innovation.

Latin America

• Brazil is emerging as a hub for biotechnology research, with universities and research institutions collaborating on protein sequencing projects, which is expected to boost local expertise and innovation.
• Regulatory frameworks in Latin America are gradually evolving to support biotechnology advancements, which may facilitate the growth of the protein sequencing market in the region.

North America

• The U.S. National Institutes of Health (NIH) has launched several initiatives aimed at advancing protein sequencing technologies, which is expected to enhance research capabilities and foster innovation in the region.
• Key players like Illumina and Thermo Fisher Scientific are investing heavily in R&D to develop next-generation sequencing technologies, which are anticipated to significantly improve the accuracy and efficiency of protein sequencing.

Middle East And Africa

• The establishment of research centers in countries like South Africa and the UAE is fostering collaboration in protein sequencing research, which is expected to enhance local capabilities and attract international partnerships.
• Government initiatives aimed at improving healthcare infrastructure in the region are likely to increase the adoption of advanced protein sequencing technologies.

Did You Know?

“Did you know that protein sequencing can provide insights into the structure and function of proteins, which are crucial for understanding diseases and developing targeted therapies?” — National Institutes of Health (NIH)

Segmental Market Size

This report is an analysis of the current state of the market for the global market for protein sequencing. The market is characterized by the increasing occurrence of chronic diseases that require accurate analysis of proteins for proper treatment, as well as technological developments that improve the accuracy and reduce the cost of protein sequencing. These developments have led to a rise in the use of these methods in many regions, especially in North America and Europe, where there is significant funding for research. In the current situation, the market is in the process of deploying the technology, which is used in the field of drug discovery, biomarkers, and agricultural biotechnology. There are also examples of the development of monoclonal antibodies and the improvement of the properties of plants through the use of protein analysis. The pandemic of COV19 and other macro trends are increasing the need for quick diagnostics and the development of vaccines. The future of the market for protein sequencing is characterized by mass spectrometry and next-generation sequencing, which unlock new insights in the field of genomics and proteomics.

Future Outlook

The market for proteomics is set to grow at a CAGR of 14.46% from 2024 to 2035, registering a growth from $1.4bn to $6.5bn. This growth is driven by the advancement in sequencing technology, the rising demand for personalised medicine, and the increase in the prevalence of chronic diseases which require detailed proteomic analysis. This is in line with the global shift towards a more personalised medicine. The penetration of proteomics is set to rise further in clinical settings, reaching over 30% in research and diagnostics by 2035. The key technological developments include the advancements in next-generation sequencing (NGS) and mass spectrometry, which have improved the accuracy and speed of the analysis. Artificial intelligence and machine learning are also expected to improve the data interpretation and thus increase the efficiency of proteomic research. The focus on biomarker discovery and the increasing investment in biotechnology are expected to further propel the market growth. The development of regulatory frameworks which support the use of proteomic solutions will also drive the growth of the market.